- Home
- SAFT vs YDES Comparison
SAFT vs YDES Comparison
Compare SAFT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SAFT | YDES |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SAFT | YDES |
|---|---|---|
| Price | $78.20 | $11.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 96.0K | ★ 110.9K |
| Earning Date | 11-03-2025 | 09-30-2025 |
| Dividend Yield | ★ 4.70% | N/A |
| EPS Growth | ★ 15.78 | N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | ★ $1,231,116,000.00 | $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | 12.77 | ★ 45.76 |
| 52 Week Low | $67.04 | $5.30 |
| 52 Week High | $85.12 | $31.00 |
Technical Indicators
Market Signals| Indicator | SAFT | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | N/A |
| Support Level | $73.70 | N/A |
| Resistance Level | $77.37 | N/A |
| Average True Range (ATR) | 1.59 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 88.78 | 0.00 |
Price Performance
Historical ComparisonAbout SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.